OncoNick
Suchy Las
About OncoNick
OncoNick is a therapeutic agent engineered for the precise delivery of cytotoxic drugs to lung cancer cells.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $260.4K
- Funding stage: Seed
- Last round: Pre-Seed (Jan 2020)
- Website: onconick.pl
Industries & Categories
Manufacturing, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/onconick-220523 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.